Neuropsychiatric Syndromes in Systemic Lupus Erythematosus: A Meta-Analysis

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 1, 2011, Pages 1-11

  Unterman, Avraham ^a,b   Nolte, Johannes E S ^a,b   Boaz, Mona ^b,c   Abady, Maya ^d   Shoenfeld, Yehuda ^a,b   Zandman Goddard, Gisele ^b,c  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

^d Edgecliff Physiotherapy Sports and Spinal Centre   (Australia)

Author keywords

American College of Rheumatology; Meta analysis; Neuropsychiatric; Prevalence; Systemic lupus erythematosus

Indexed keywords

ACUTE CONFUSION; ANXIETY DISORDER; ARTICLE; ASIAN; AUTONOMIC DYSFUNCTION; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; DISEASE DURATION; ETHNIC DIFFERENCE; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; MENTAL DISEASE; MONONEUROPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOSIS; RETROSPECTIVE STUDY; SEIZURE; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

COGNITION DISORDERS; HEADACHE; HUMANS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MOOD DISORDERS; PREVALENCE; SOCIETIES, MEDICAL; SYNDROME;

EID: 80051472797     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2010.08.001     Document Type: Article

References (50)

1. Borchers A.T., Aoki C.A., Naguwa S.M., Keen C.L., Shoenfeld Y., Gershwin M.E. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun Rev 2005, 4(6):329-344.
2. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999, 42(4):599-608.
3. Abdel-Nasser A.M., Ghaleb R.M., Mahmoud J.A., Khairy W., Mahmoud R.M. Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 2008, 27:1377-1385.
4. Appenzeller S., Rondina J.M., Li L.M., Costallat L.T., Cendes F. Cerebral and corpus callosum atrophy in systemic lupus erythematosus. Arthritis Rheum 2005, 52(9):2783-2789.
5. Zhou H.Q., Zhang F.C., Tian X.P., Leng X.M., Lu J.J., Zhao Y., et al. Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus 2008, 17(2):93-99.
6. Spinosa M.J., Bandeira M., Liberalesso P.B., Vieira S.C., Janz L.L., Sa E.G., et al. Clinical, laboratory and neuroimage findings in juvenile systemic lupus erythematosus presenting involvement of the nervous system. Arq Neuropsiquiatr 2007, 65(2B):433-439.
7. Avcin T., Benseler S.M., Tyrrell P.N., Cucnik S., Silverman E.D. A follow up study of antiphospholipid antibodies and associated neuropsychiatric manifestations in 137 children with systemic lupus erythematosus. Arthritis Rheum 2008, 59(2):206-213.
8. Sibbitt W.L., Brandt J.R., Johnson C.R., Maldonado M.E., Patel S.R., Ford C.C., et al. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol 2002, 29(7):1536-1542.
9. Mok C.C., To C.H., Mak A. Neuropsychiatric damage in Southern Chinese patients with systemic lupus erythematosus. Medicine (Baltimore) 2006, 85(4):221-228.
10. Afeltra A., Garzia P., Mitterhofer A.P., Vadacca M., Galluzzo S., Del Porto F., et al. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 2003, 61(1):108-110.
11. Harel L., Sandborg C., Lee T., von Scheven E. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 2006, 33(9):1873-1877.
12. Yu H.H., Lee J.H., Wang L.C., Yang Y.H., Chiang B.L. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus 2006, 15(10):651-657.
13. Sanna G., Bertolaccini M.L., Cuadrado M.J., Laing H., Khamashta M.A., Mathieu A., et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003, 30(5):985-992.
14. Robert M., Sunitha R., Thulaseedharan N.K. Neuropsychiatric manifestations systemic lupus erythematosus: a study from South India. Neurol India 2006, 54(1):75-77.
15. Brey R.L., Holliday S.L., Saklad A.R., Navarrete M.G., Hermosillo-Romo D., Stallworth C.L., et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002, 58(8):1214-1220.
16. Ainiala H., Loukkola J., Peltola J., Korpela M., Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001, 57(3):496-500.
17. Mok C.C., Lau C.S., Wong R.W. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 2001, 28(4):766-771.
18. Schenatto C.B., Xavier R.M., Bredemeier M., Portela L.V., Tort A.B., Dedavid e Silva T.L., et al. Raised serum S100B protein levels in neuropsychiatric lupus. Ann Rheum Dis 2006, 65(6):829-831.
19. Hanly J.G., Urowitz M.B., Su L., Sanchez-Guerrero J., Bae S.C., Gordon C., et al. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum 2008, 59(5):721-729.
20. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283(15):2008-2012.
21. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
22. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
23. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22(4):719-748.
24. Egger M., Smith G.D., Phillips A.N. Meta-analysis: principles and procedures. BMJ 1997, 315(7121):1533-1537.
25. Abramson J.H. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004, 1(1):6.
26. Muscal E., Myones B.L. The role of autoantibodies in pediatric neuropsychiatric systemic lupus erythematosus. Autoimmun Rev 2007, 6(4):215-217.
27. Mitsikostas D.D., Sfikakis P.P., Goadsby P.J. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain 2004, 127(Pt5):1200-1209.
28. Kozora E., Ellison M.C., West S. Reliability and validity of the proposed American College of Rheumatology neuropsychological battery for systemic lupus erythematosus. Arthritis Rheum 2004, 51(5):810-818.
29. Hanly J.G., Robichaud J., Fisk J.D. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006, 33(8):1553-1558.
30. Sabbadini M.G., Manfredi A.A., Bozzolo E., Ferrario L., Rugarli C., Scorza R., et al. Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations. Lupus 1999, 8(1):11-19.
31. Tomietto P., Annese V., D'Agostini S., Venturini P., La Torre G., De Vita S., et al. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007, 57(8):1461-1472.
32. Assal F., Blanche P., Lamy C., Sicard D., De Recondo J. [Brachial plexus involvement disclosing systemic lupus erythematosus]. Presse Med 1993, 22(12):598.
33. Bloch S.L., Jarrett M.P., Swerdlow M., Grayzel A.I. Brachial plexus neuropathy as the initial presentation of systemic lupus erythematosus. Neurology 1979, 29:1633-1634.
34. Siekert R.G., Clark E.C. Neurologic signs and symptoms as early manifestations of systemic lupus erythematosus. Neurology 1955, 5(2):84-88.
35. Robson M.G., Walport M.J., Davies K.A. Systemic lupus erythematosus and acute demyelinating polyneuropathy. Br J Rheumatol 1994, 33(11):1074-1077.
36. Leneman F. The Guillain-Barre syndrome. Definition, etiology, and review of 1,100 cases. Arch Intern Med 1966, 118(2):139-144.
37. Hughes R.A., Rees J.H. Clinical and epidemiologic features of Guillain-Barre syndrome. J Infect Dis 1997, 176(Suppl 2):S92-S98.
38. Shalimar, Handa R., Deepak K.K., Bhatia M., Aggarwal P., Pandey R.M. Autonomic dysfunction in systemic lupus erythematosus. Rheumatol Int 2006, 26(9):837-840.
39. Omdal R., Jorde R., Mellgren S.I., Husby G. Autonomic function in systemic lupus erythematosus. Lupus 1994, 3(5):413-417.
40. Vaiopoulos G., Sfikakis P.P., Kapsimali V., Boki K., Panayiotidis P., Aessopos A., et al. The association of systemic lupus erythematosus and myasthenia gravis. Postgrad Med J 1994, 70(828):741-745.
41. Sthoeger Z., Neiman A., Elbirt D., Zinger H., Magen E., Burstein R., et al. High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study. Am J Med Sci 2006, 331(1):4-9.
42. Bhinder S., Majithia V., Harisdangkul V. Myasthenia gravis and systemic lupus erythematosus: truly associated or coincidental-two case reports and review of the literature. Clin Rheumatol 2006, 25(4):555-556.
43. Uribe A.G., McGwin G., Reveille J.D., Alarcon G.S. What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort?. Where are we heading?. Autoimmun Rev 2004, 3(4):321-329.
44. Herbison P., Hay-Smith J., Gillespie W.J. Adjustment of meta-analyses on the basis of quality scores should be abandoned. J Clin Epidemiol 2006, 59(12):1249-1256.
45. Juni P., Witschi A., Bloch R., Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999, 282(11):1054-1060.
46. Sanchez-Guerrero J., Aranow C., Mackay M., Volpe B., Diamond B. Neuropsychiatric systemic lupus erythematosus reconsidered. Nat Clin Pract Rheumatol 2008, 4(3):112-113.
47. Zandman-Goddard G., Chapman J., Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 2007, 36(5):297-315.
48. Sofat N., Malik O., Higgens C.S. Neurological involvement in patients with rheumatic disease. QJM 2006, 99(2):69-79.
49. Hanly J.G., Fisk J.D., McCurdy G., Fougere L., Douglas J.A. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 2005, 32(8):1459-1466.
50. Ainiala H., Hietaharju A., Loukkola J., Peltola J., Korpela M., Metsanoja R., et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001, 45(5):419-423.